On 2 June 2021, the antibody-drug combination by the US drugmaker Eli Lilly was granted EUA[1] in India. This combination was permitted for the treatment of mild to moderate COVID -19 in India. The monoclonal antibody drugs, bamlanivimab 700 mg, and etesevimab 1400 mg, have received permission for restricted use. Eli Lilly has stated that […]
JB Chemicals & Pharma launches NOSMOK nicotine lozenges to help with smoking cessation : On 31 May 2021, JB Chemicals and Pharmaceuticals launched medicated nicotine lozenges. An artificial intelligence-enabled chatbot called ‘Dr. Will’ was also launched alongside this product. [1] The drug makers used the occasion of the “World No Tobacco Day” for the launch.
Dr. Reddy’s to charge Rs. 990 for each sachet of the anti-COVID-19 medicine by DRDO (2-DG) Dr. Reddy’s has recently fixed the price of DRDO’s[1] 2-DG (2-deoxy-D-glucose) at Rs. 990 per sachet. It was revealed that this would be provided in the central and state government hospitals at a discounted price. 2-DG is an anti-COVID-19
GSK and Vir Biotechnology plan to launch Sotrovimab for treating COVID-19 in India : GlaxoSmithKline (GSK), together with the US-based Vir Biotechnology, is planning to launch a single-dose mAb[1] in India. This drug is called Sotrovimab (VIR-7831) and has received the EUA[2] from the USFDA[3]. It was approved for treating mild to moderate COVID-19 in high-risk
GSK and Vir Biotechnology plan to launch Sotrovimab Read More »
US pharma firms Gilead and Mylan deliver 50,000 vials of Amphotericin B to India : India received around 50,000 vials of Amphotericin-B from US-based Gilead Sciences and Mylan on 28 May 2021. This drug is used for treating patients with black fungus. The Union Minister of State for Chemicals and Fertilizers has expressed his gratitude
pharma News June 2021: Read what is happening in India and around the globe in the pharma industry. AstraZeneca’s India vaccine partner seeking EU travel resolution: 28 June 2021 European Union’s vaccine passport program has allowed only people vaccinated with one of the four Western-made vaccines to travel within the bloc from 1 July 2021.
Zydus seeks DCGI’s approval for conducting clinical trials of its COVID-19 biological therapy : Zydus Cadila has recently sought the DCGI’s[1] approval for conducting clinical trials of its new COVID-19 treatment. This is a monoclonal antibody (mAb) based cocktail that can neutralize COVID-19 infection. 1 The pharma firm stated that the antibodies are made by cloning
Zydus seeks DCGI’s approval for COVID-19 biological therapy Read More »
Zydus and TLC sign a pact to commercialize AmphoTLC in India Zydus Cadila and Taiwan-based pharma firm TLC have signed a pact to market Liposomal Amphotericin B (AmphoTLC) in India. This news was disclosed on 26 May 2021. 1 The companies have decided to commercialize AmphoTLC (Amphotericin B Liposome for Injection 500 mg) in India.
Zydus and TLC to commercialize AmphoTLC in India Read More »
Sun Pharma recalls Metformin HCl tablets from the US market due to contamination by activated carbon : Sun Pharma recalls a diabetes drug called Metformin Hydrochloride (HCl) tablets, 500 mg from the US[1] market. Over 50,868 bottles of these extended-release tablets are being recalled as per the USFDA[2]. The US health regulator stated that the
Sun Pharma recalls Metformin tablets from the US market Read More »
Pfizer – BioNTech pledge to supply 2 billion doses to middle – and low – income countries within 18 months : On 21 May 2021, Pfizer and BioNTech pledged to deliver around 2 billion doses of its COVID – 19 vaccine to less wealthy nations. The companies stated that they would supply these doses to
Pfizer – BioNTech pledge to supply 2 billion doses Read More »
